Could cause temporary or reversible harm; serious harm is unlikely.
Failed Dissolution Specifications: During 12-month long-term stability testing, subject lot was out of specification (low) for stage 3 dissolution at the 24-hour timepoint.
| Brand name | NIACIN |
| Generic name | NIACIN |
| Active ingredient(s) | NIACIN |
| Distributed by / for | Golden State Medical Supply Inc. |
| NDC | 51407-268-90 |
| Full product label | GSMS Incorporated, NIACIN EXTENDED-RELEASE TABLETS, USP, 1,000 MG, 90 tablets, Rx only, Manufactured by Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannett, Inc., Seymour, IN 47274, Packaged by GSMS Incorporated, Camarillo, CA 93012. NDC 51407-268-90. |
| Recalling firm | Golden State Medical Supply Inc. |
| Distribution | Within the U.S Market. |
| Quantity | 2,961 bottles |
| Recall initiated | 2026-05-29 |
| Report date | 2026-06-17 |
| Recall completed | — |
| Recall number | D-0587-2026 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Camarillo CA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗